Stoke Therapeutics, Inc. Interest Expense in USD from 2023 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Stoke Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2023 to Q3 2025.
  • Stoke Therapeutics, Inc. Interest Expense for the quarter ending September 30, 2025 was $3K.
  • Stoke Therapeutics, Inc. Interest Expense for the twelve months ending September 30, 2025 was $6K.
  • Stoke Therapeutics, Inc. annual Interest Expense for 2024 was $26K, a 46.9% decline from 2023.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)

Stoke Therapeutics, Inc. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $6K $3K +$3K Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-04
Q2 2025 $3K $3K -$2K -40% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-12
Q1 2025 $5K $1K -$21K -95.5% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q4 2024 $26K -$1K Oct 1, 2024 Dec 31, 2024 10-K 2025-03-18
Q3 2024 $0 Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-04
Q2 2024 $5K Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-12
Q1 2024 $22K Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13

Stoke Therapeutics, Inc. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $26K -$23K -46.9% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-18
2023 $49K Jan 1, 2023 Dec 31, 2023 10-K 2025-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.